Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.
Clinical trial NCT04033991 · COMPLETED
Trial details
- NCT number
- NCT04033991
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-09-27
- Primary completion
- 2020-12-18
- Enrollment
- 684
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.